Trial Profile
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 400mg/Day and 600mg/Day SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jun 2015
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors UCB
- 25 Apr 2015 Results of pooled and subgroup analysis presented at the 67th Annual Meeting of the American Academy of Neurology.
- 12 Jan 2010 Results have been online ahead of print in Diabetes Care.
- 19 Sep 2006 New trial record.